Pathophysiological aspects of memory B-cell development

Trends in Immunology

Volumn 29, Issue 1, 2008, Pages 25-33

  Roulland, Sandrine ^a,b,c   Suarez, Felipe ^d   Hermine, Olivier ^c,d   Nadel, Bertrand ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; VIRUS ANTIGEN;

ANTIBODY RESPONSE; B CELL LYMPHOMA; CARCINOGENESIS; CELL MATURATION; CHRONIC GASTRITIS; DISEASE ASSOCIATION; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELPER CELL; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE PROLIFERATION; MARGINAL ZONE LYMPHOMA; MEMORY CELL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; CELL DIFFERENTIATION; GERMINAL CENTER; HELICOBACTER PYLORI; HEPACIVIRUS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; PLASMA CELLS; T-LYMPHOCYTES;

EID: 37849054426     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.10.005     Document Type: Review

References (86)

1. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5 (2005) 251-262
2. Shaffer A.L., et al. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2 (2002) 920-932
3. Suarez F., et al. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107 (2006) 3034-3044
4. Fisher S.G., and Fisher R.I. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr. Opin. Oncol. 18 (2006) 417-424
5. Harris N.L., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
6. Wotherspoon A.C., et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338 (1991) 1175-1176
7. Lecuit M., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350 (2004) 239-248
8. Goodlad J.R., et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am. J. Surg. Pathol. 24 (2000) 1279-1285
9. Ferreri A.J., et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl. Cancer Inst. 96 (2004) 586-594
10. Hermine O., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 89-94
11. Saadoun D., et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?. Blood 105 (2005) 74-76
12. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3 (2003) 801-812
13. Pillai S., et al. Marginal zone B cells. Annu. Rev. Immunol. 23 (2005) 161-196
14. Morse III H.C., et al. Cells of the marginal zone-origins, function and neoplasia. Leuk. Res. 25 (2001) 169-178
15. Sagaert X., et al. The pathogenesis of MALT lymphomas: where do we stand?. Leukemia 21 (2007) 389-396
16. Cavalli F., et al. MALT lymphomas. Hematology (Am. Soc. Hematol. Educ. Program) (2001) 241-258
17. Wotherspoon A.C., et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342 (1993) 575-577
18. Wotherspoon A.C., et al. Antibiotic treatment for low-grade gastric MALT lymphoma. Lancet 343 (1994) 1503
19. Bayerdorffer E., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345 (1995) 1591-1594
20. Zucca E., et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N. Engl. J. Med. 338 (1998) 804-810
21. Zucca E., et al. Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach. Leukemia 12 (1998) 247-249
22. Bende R.J., et al. Among B cell non-Hodgkin's lymphomas. MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201 (2005) 1229-1241
23. Hussell T., et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342 (1993) 571-574
24. Weller S., et al. Splenic marginal zone B cells in humans: where do they mutate their Ig receptor? Eur. J. Immunol. 35 (2005) 2789-2792
25. Willenbrock K., et al. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase. Eur. J. Immunol. 35 (2005) 3002-3007
26. Bernasconi N.L., et al. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
27. Isaacson P.G., and Du M.Q. MALT lymphoma: from morphology to molecules. Nat. Rev. Cancer 4 (2004) 644-653
28. Farinha P., and Gascoyne R.D. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J. Clin. Oncol. 23 (2005) 6370-6378
29. Bertoni F., and Zucca E. Delving deeper into MALT lymphoma biology. J. Clin. Invest. 116 (2006) 22-26
30. Du M.Q., and Atherton J.C. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 55 (2006) 886-893
31. Troussard X., et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br. J. Haematol. 93 (1996) 731-736
32. Thieblemont C., et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol. 4 (2003) 95-103
33. Quinn E.R., et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98 (2001) 3745-3749
34. Chan C.H., et al. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97 (2001) 1023-1026
35. Carbonari M., et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J. Immunol. 174 (2005) 6532-6539
36. De Re V., et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96 (2000) 3578-3584
37. Hu Y.W., et al. Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2. Virology 332 (2005) 538-549
38. Cormier E.G., et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 14067-14072
39. Takaki A., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6 (2000) 578-582
40. Besson C., et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J. Clin. Oncol. 24 (2006) 953-960
41. Giannelli F., et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 102 (2003) 1196-1201
42. Weller S., et al. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol. 26 (2005) 85-89
43. Bahler D.W., et al. Splenic marginal zone lymphomas appear to originate from different B cell types. Am. J. Pathol. 161 (2002) 81-88
44. Tierens A., et al. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood 91 (1998) 2381-2386
45. Tierens A., et al. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am. J. Pathol. 162 (2003) 681-689
46. Traverse-Glehen A., et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica 90 (2005) 470-478
47. De Re V., et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20 (2006) 1145-1154
48. Marculescu R., et al. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair (Amst.) 5 (2006) 1246-1258
49. Greeve J., et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 101 (2003) 3574-3580
50. Vaandrager J.W., et al. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood 92 (1998) 2871-2878
51. Bognar A., et al. Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia 19 (2005) 1656-1662
52. Cong P., et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99 (2002) 3376-3382
53. Oeschger S., et al. Tumor cell dissemination in follicular lymphoma. Blood 99 (2002) 2192-2198
54. Ramiro A.R., et al. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118 (2004) 431-438
55. McDonnell T.J., and Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349 (1991) 254-256
56. McDonnell T.J., et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57 (1989) 79-88
57. Limpens J., et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6 (1991) 2271-2276
58. Liu Y., et al. BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8910-8914
59. Roulland S., et al. BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features. Int. J. Cancer 104 (2003) 695-698
60. Roulland S., et al. Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals. Leukemia 20 (2006) 158-162
61. Roulland S., et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J. Exp. Med. 203 (2006) 2425-2431
62. Roulland S., et al. Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. Cancer Res. 64 (2004) 2264-2269
63. Chiu B.C., et al. Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma. Blood 108 (2006) 1363-1369
64. Kitay-Cohen Y., et al. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96 (2000) 2910-2912
65. Zuckerman E., et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97 (2001) 1555-1559
66. Smith K.G., et al. bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells. J. Exp. Med. 191 (2000) 475-484
67. Bende R.J., et al. Molecular pathways in follicular lymphoma. Leukemia 21 (2007) 18-29
68. Rosa D., et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18544-18549
69. Irish J.M., et al. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 108 (2006) 3135-3142
70. Egle A., et al. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103 (2004) 2276-2283
71. Radcliffe C.M., et al. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J. Biol. Chem. 282 (2007) 7405-7415
72. Staudt L.M. A closer look at follicular lymphoma. N. Engl. J. Med. 356 (2007) 741-742
73. Carsetti R., et al. Peripheral development of B cells in mouse and man. Immunol. Rev. 197 (2004) 179-191
74. Mebius R.E., and Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 5 (2005) 606-616
75. Sims G.P., et al. Identification and characterization of circulating human transitional B cells. Blood 105 (2005) 4390-4398
76. Loder F., et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190 (1999) 75-89
77. Allman D., et al. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol. Rev. 197 (2004) 147-160
78. Su T.T., et al. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197 (2004) 161-178
79. + B cells: memory B cells or 'memory' B cells?. J. Immunol. 179 (2007) 13-19
80. Kruetzmann S., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197 (2003) 939-945
81. Weller S., et al. Human blood IgM 'memory' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104 (2004) 3647-3654
82. McHeyzer-Williams L.J., et al. Checkpoints in memory B-cell evolution. Immunol. Rev. 211 (2006) 255-268
83. Vinuesa C.G., et al. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5 (2005) 853-865
84. Paramithiotis E., and Cooper M.D. Memory B lymphocytes migrate to bone marrow in humans. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 208-212
85. O'Connor B.P., et al. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J. Exp. Med. 195 (2002) 737-745
86. Lanzavecchia A., et al. Understanding and making use of human memory B cells. Immunol. Rev. 211 (2006) 303-309